Search
01/02/2026
Lessons from the Colombian kindred: rethinking Alzheimer's prevention
Fortea, J, Llibre-Guerra, J, O'Connor, A, Levin, J. Lessons from the Colombian kindred: rethinking Alzheimer's prevention. LANCET NEUROLOGY. 2026; 25(2)DOI:10.1016/S1474-4422(25)00481-8. PMID:41579884. IF:45.500(Q1/1D).
01/02/2026
Perioperative care in primary retroperitoneal sarcoma surgery: A hispano-luso survey on current practices
Lominchar, PL, Muñoz, P, Ballester, C, Casares, CM, Diaz, D, Olivares-Ripoll, V, Marrero, P, Cambeiro, L, Lopez, I, Vasques, H, Asencio, JM. Perioperative care in primary retroperitoneal sarcoma surgery: A hispano-luso survey on current practices. CIRUGIA ESPANOLA. 2026; 104(2)DOI:10.1016/j.ciresp.2025.800283. PMID:. IF:1.300(Q3/7D).
01/02/2026
Grading of Recommendations, Assessment, Development, and Evaluation guidance 44: strategies to enhance the utilization of randomized and nonrandomized studies in evidence syntheses of healthinterventions
Cuello-Garcia, CA, Morgan, RL, Santesso, N, Alonso-Coello, P, Brignardello-Petersen, R, Schwingshackl, L, Brozek, JL, Katikireddi, SV, Munn, Z, Waddington, HS, Wilson, KC, Meerpohl, J, Morales, D, Neumann, I, Tugwell, P, Guyatt, G, Schünemann, HJ. Grading of Recommendations, Assessment, Development, and Evaluation guidance 44: strategies to enhance the utilization of randomized and nonrandomized studies in evidence syntheses of healthinterventions. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2026; 190DOI:10.1016/j.jclinepi.2025.112086. PMID:41285282. IF:5.200(Q1/1D).
01/02/2026
The Risk of Bias in Vaccine Effectiveness (RoB-VE) project: introduction to a methodological initiative to improve risk-of-bias assessment and reporting in vaccine effectiveness research
Laurie, C, Coello, PA, Florez, ID, Le, M, Moher, D, Sadarangani, M, Sundaram, ME, Wells, G, Wilkinson, K, Dwan, K, Halperin, SA, Nicholls, SG, Reeves, BC, Waddington, HS, Shea, B, Brouwers, M, Sulis, G. The Risk of Bias in Vaccine Effectiveness (RoB-VE) project: introduction to a methodological initiative to improve risk-of-bias assessment and reporting in vaccine effectiveness research. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2026; 190DOI:10.1016/j.jclinepi.2025.112088. PMID:41297718. IF:5.200(Q1/1D).
01/02/2026
Appropriateness criteria in the request for carotid ultrasonography. A multicentre study
Armario, P, Bellmunt, S, Rodriguez, JLD, Zapater, CJ, Gich, IJ, Roure, P, Canabal, EF, Requeijo, C. Appropriateness criteria in the request for carotid ultrasonography. A multicentre study. MEDICINA CLINICA. 2026; 166(2)DOI:10.1016/j.medcli.2025.107346. PMID:41548329. IF:2.100(Q2/3D).
01/02/2026
Sex differences in HIV testing in Catalan emergency departments
Robert, N, Miro, E, Llaneras, J, Guardiola, JM, Smithson, A, Leey, C, Bustamante, MA, Ferro, JI, Michelini, M, Martínez, A, Saura, M, Viñas, J, del Castillo, JG, Gené, E, Miro, O. Sex differences in HIV testing in Catalan emergency departments. European Journal of Emergency Medicine. 2026; 33(1)DOI:10.1097/MEJ.0000000000001291. PMID:41258674. IF:4.200(Q1/1D).
01/02/2026
Analysis on workforce availability, education and training needs for medical physics experts to ensure quality and safety of medical applications involving ionising radiation in the EU - Status and recommendations from the EU-REST project
Garibaldi, C, Sánchez, RM, Visvikis, D, Pesznyak, C, Polycarpou, I, Koutsouveli, E, Jornet, N. Analysis on workforce availability, education and training needs for medical physics experts to ensure quality and safety of medical applications involving ionising radiation in the EU - Status and recommendations from the EU-REST project. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2026; 142DOI:10.1016/j.ejmp.2026.105724. PMID:41544482. IF:2.700(Q2/4D).
01/02/2026
Neurodegeneration in Langerhans cell histiocytosis: Beyond a sequela
López, VS, Gutiérrez-Carrasco, I, Pérez-Martinez, A, Iturrate, CRV, Garcia-Obregón, S, Reggiori, ML, Carrillo, TM, Valero-Arrese, L, Torrent, M, Astigarraga, I. Neurodegeneration in Langerhans cell histiocytosis: Beyond a sequela. ANALES DE PEDIATRIA. 2026; 104(2)DOI:10.1016/j.anpedi.2025.504058. PMID:. IF:2.100(Q2/4D).
01/02/2026
Corticosteroid-responsive optic neuritis associated with acute retinal necrosis due to Herpes simplex virus type 2 in a pediatric patient
Montero-Garcia, A, Pérez-Garcia, G, Cobo-De-Nadal, M, Verdú-Reyes, A, Díaz-Cascajosa, J. Corticosteroid-responsive optic neuritis associated with acute retinal necrosis due to Herpes simplex virus type 2 in a pediatric patient. JOURNAL FRANCAIS D OPHTALMOLOGIE. 2026; 49(2)DOI:10.1016/j.jfo.2025.104760. PMID:41512673. IF:1.100(Q3/8D).
01/02/2026
Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort
Ardébol, SB, Pérez-Pastor, GM, Fernández-de-Misa, R, Botella-Estrada, R, Ruiz-Salas, V, Flórez, A, Arenal, MM, González, MJF, Bassas-Freixas, P, Toll, A, Almazán, PV, Arntz, R, Malvehy, J. Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort. Actas Dermo-Sifiliograficas. 2026; 117(2)DOI:10.1016/j.ad.2025.104524. PMID:41352588. IF:(Q/D).
01/02/2026
Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review
Baniandres, O, Franch, IB, Rull, EV, Moya, AI, Pacheco, MLA, Puchades, AM, Sánchez, JPH, Diaz, FJM, Ruiz, AB, Cantero, AG, Lorenzo, EM, Gutierrez, MG, Fernández-Freire, LR, Payeras, AV, Santos, CM, Bel, PH, Ostiz, SH, Montcusi, JP, Salafranca, MA, Segura, PC, Pallas, IM, Masoliver, AA, Manchón, TM, Mucientes, CD, Apetrei, CLS, Martinez, AB, Serrano, JM, Ortega, CP, del Cura, LR, Barragán, IL, Mur, EC, Olivares, MG, Dobao, PD. Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(2)DOI:10.1111/ijd.70053. PMID:40931458. IF:3.200(Q1/3D).
01/02/2026
Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors
Ara-Martín, M, Moreno, C, Ruiz-Villaverde, R, Serra-Baldrich, E, Hernández-Martín, I, Fortes, MD. Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(2)DOI:10.1111/ijd.70033. PMID:40928003. IF:3.200(Q1/3D).
01/02/2026
Ex-vivo digital pathological imaging with the Vivascope confocal microscopy for intraoperative diagnostics during ureterorenoscopy for upper tract urothelial cancer
Afferi, L, Territo, A, Gallioli, A, Verri, P, Basile, G, Uleri, A, Cannoletta, D, Casadevall, M, Diana, P, Gavrilov, P, Arce, Y, Gaya, JM, Palou, J, Arrea, FA, Breda, A. Ex-vivo digital pathological imaging with the Vivascope confocal microscopy for intraoperative diagnostics during ureterorenoscopy for upper tract urothelial cancer. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; 44(2)DOI:10.1016/j.urolonc.2025.11.009. PMID:41372082. IF:2.300(Q2/5D).
01/02/2026
The impact of large-scale release of Wolbachia mosquitoes on dengue incidence in Campo Grande, Brazil: an ecological study
Batista, FD, Carcamo, PM, Nelson, E, Neto, ABD, Tsuha, DH, Lahdo, V, dos Santos, VR, Ribeiro, GS, Lopes, RD, Amadeu, P, Blanco, MVFM, da Costa, TR, Chalegre, KDD, Riback, TIS, da Silva, CC, Ranzani, OT, Cummings, DAT, Andrews, JR, Ko, AI, Hitchings, MDT, Anders, KL, Moreira, LA, Gonçalves, CCM, Croda, J. The impact of large-scale release of Wolbachia mosquitoes on dengue incidence in Campo Grande, Brazil: an ecological study. Lancet Regional Health-Americas. 2026; 54DOI:10.1016/j.lana.2025.101327. PMID:41438239. IF:(Q/D).
01/02/2026
Neoadjuvant (neoadj) durvalumab (D) plus chemotherapy (CT) followed by either surgery (Sx) and adjuvant D or CRT and consolidation D in patients (pts) with resectable or borderline resectable stage IIB-IIIB NSCLC: interim analysis (IA) of the phase 2 MDT-BRIDGE study
Buchmeier, EL, Reck, M, Girard, N, Nadal, E, Gay, CM, Filippi, AR, Martin, LW, Petersen, C, Cairns, DA, Roch, B, Attili, I, Alvarez, RA, Boyer, A, Tarruella, MM, Robinson, A, Levra, MG, Li, L, Perez, ID, Georgoulia, N, Spicer, J. Neoadjuvant (neoadj) durvalumab (D) plus chemotherapy (CT) followed by either surgery (Sx) and adjuvant D or CRT and consolidation D in patients (pts) with resectable or borderline resectable stage IIB-IIIB NSCLC: interim analysis (IA) of the phase 2 MDT-BRIDGE study. Oncology Research and Treatment. 2026; 49DOI:. PMID:. IF:1.600(Q4/9D).
01/02/2026
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease
Giani, C, Baldi, GG, Ljevar, S, Denu, RA, Andelkovic, V, Han, I, Brunello, A, Napolitano, A, Bhadri, VA, Scanferla, R, Garcia, AS, Abreu, MH, Campos, F, Ogura, K, Wong, DD, Bae, S, Marquina, G, Mazzocca, A, Yang, V, Nakazawa, MS, Kim, HS, Chiusole, B, Thway, K, Antonescu, C, Bellan, E, Bovée, JVMG, Davis, JL, Tos, APD, Di Blasi, E, Lazar, AJ, Sbaraglia, M, Schaefer, IM, Taverna, S, Chen, TWW, Miceli, R, Gronchi, A, Stacchiotti, S. International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease. ESMO Open. 2026; 11(2)DOI:10.1016/j.esmoop.2025.106044. PMID:41564817. IF:8.300(Q1/2D).
01/02/2026
IMforte: Results from a Phase 3 study of first-line (1L) maintenance treatment (tx) with lurbinectedin (lurbi) plus atezolizumab (atezo) vs atezo in patients (pts) with ES-SCLC
Christoph, D, Paz-Ares, L, Borghaei, H, Liu, S, Peters, S, Herbst, R, Stencel, K, Tarruella, MM, Czyzewicz, G, Caro, RB, Lee, KH, Johnson, ML, Karadurmus, N, Grohé, C, Cuchelkar, V, Graupner, V, Kaul, M, Lin, YC, Chakrabarti, D, Bhatt, K, Reck, M. IMforte: Results from a Phase 3 study of first-line (1L) maintenance treatment (tx) with lurbinectedin (lurbi) plus atezolizumab (atezo) vs atezo in patients (pts) with ES-SCLC. Oncology Research and Treatment. 2026; 49DOI:. PMID:. IF:1.600(Q4/9D).
01/02/2026
Socioeconomic Deprivation in Ischemic Stroke Treated With Endovascular Thrombectomy: Not All Recoveries Are Equal
Montalvo, C, Garcia-Tornel, A, Olive-Gadea, M, Rodrigo-Gisbert, M, Requena, M, Rizzo, F, Rodriguez-Luna, D, Rodriguez-Villatoro, N, Pagola, J, Simonetti, R, de la Ossa, NP, Camps-Renom, P, Canovas, D, Flores, A, Rodriguez-Campello, A, Silva, Y, Urra, X, Purroy, F, Bustamante, A, Salvat-Plana, M, Cardona, P, Molina, C, Rubiera, M, Ribo, M. Socioeconomic Deprivation in Ischemic Stroke Treated With Endovascular Thrombectomy: Not All Recoveries Are Equal. STROKE. 2026; 57(2)DOI:10.1161/STROKEAHA.125.052865. PMID:41208686. IF:8.900(Q1/1D).
01/02/2026
White Matter Hyperintensities Are Associated with Worse Outcomes but Not Greater Cerebral Edema or Hemorrhagic Transformation After Large Vessel Occlusion Stroke
Dietz, S, Avula, A, Kumar, A, Petersen, N, Guasch-Jimenez, M, Slowik, A, Wrona, P, Dhar, R. White Matter Hyperintensities Are Associated with Worse Outcomes but Not Greater Cerebral Edema or Hemorrhagic Transformation After Large Vessel Occlusion Stroke. STROKE. 2026; 57(SUPPL_1)DOI:10.1161/str.57.suppl_1.DP035. PMID:. IF:8.900(Q1/1D).
01/02/2026
Cardiac plasmacytoma with extensive infiltration: multimodal diagnosis and therapeutic challenges: a case report
Rodríguez-Fraga, P, Cascos, E, Cuartas, A, Espadaler, I. Cardiac plasmacytoma with extensive infiltration: multimodal diagnosis and therapeutic challenges: a case report. European Heart Journal-Case Reports. 2026; 10(2)DOI:10.1093/ehjcr/ytag102. PMID:41728229. IF:(Q/D).